AIGH Capital Management LLC acquired a new position in Regentis Biomaterials Ltd. (NYSEAMERICAN:RGNT – Free Report) during the first quarter, Holdings Channel.com reports. The firm acquired 300,000 shares of the company’s stock, valued at approximately $916,000. AIGH Capital Management LLC owned about 0.06% of Regentis Biomaterials as of its most recent SEC filing.
Regentis Biomaterials Price Performance
NYSEAMERICAN RGNT opened at $3.58 on Thursday. Regentis Biomaterials Ltd. has a 1 year low of $1.23 and a 1 year high of $15.50. The firm’s fifty day simple moving average is $2.94.
Regentis Biomaterials Profile
Read More
- Five stocks we like better than Regentis Biomaterials
- A Market Panic Just Discounted the AI Highway’s Tollbooth
- Why Exxon Could Be the Market’s Next Big Comeback Stock
- The Market Just Got Shaken—These 3 ETFs May Come Out Stronger
- Meta Platforms’ Cloud Push: Growth Opportunity Versus AI Concerns
Want to see what other hedge funds are holding RGNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Regentis Biomaterials Ltd. (NYSEAMERICAN:RGNT – Free Report).
Receive News & Ratings for Regentis Biomaterials Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Regentis Biomaterials and related companies with MarketBeat.com's FREE daily email newsletter.
